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P&l Vaccination Coverage —  Continued
Adult Blood Lead Epidemiology and Surveillance — 
United States, 1994 and First Quarter 1995
CDC's National Institute for Occupational Safety and Health (NIOSH) Adult Blood 
Lead Epidemiology and Surveillance program (ABLES) monitors elevated blood lead 
levels (BLLs) among adults in the United States (7). Twenty-three states currently re­
port surveillance results to ABLES. Maine is the 23rd state, and its data (beginning in 
1994) are included for the first time in this report. This report presents ABLES data for 
the first quarter of 1995 compared with the first quarter of 1994 and annual data for 
1994 compared with 1993.
First Quarter Reports 1995. During January-March 1995, the number of reports of 
elevated BLLs increased by 10% over those reported for the same period in 1994 
(Table 1). The number of reports increased at the lowest reporting level (25-39 pg/dL), 
but decreased at all higher reporting levels (40-49 pg/dL, 50-59 pg/dL, and >60 jig/dL). 
The trend of increasing reports at the lower levels and decreasing reports at the higher 
levels is consistent with the 1994 fourth quarter report (2 ).
Annual Reports 1994, The reported number of adults with elevated BLLs increased 
from 11,240 in 1993 to 12,137 in 1994 (Table 2); this increase resulted, in part, from the 
addition of three reporting states in 1994. A total of 5619 new cases accounted for 
46% of the cases reported in 1994, compared with 59% new cases in 1993 (Table 2). 
Compared with 1993, the proportion of new cases declined in the 25-39 pg/dL, 40-49 
pg/dL, and 50-59 pg/dL categories and increased in the £60 pg/dL category. Even with 
additional states reporting, the number of new cases decreased 15% from 1993 
through 1994 (Table 2). This decrease may be explained in part by the definition of a 
new case, which is an elevated BLL (£25 pg/dL) in an adult reported in state surveil­
lance data in the current year but which was not recorded in the immediately 
preceding year. By this definition, all persons reported represent new cases in the year 
a state begins surveillance.
Reported by: JP Lofgren, MD, Aiabama Dept o f Public Health. C Fowler, MS, Arizona Dept o f 
Health Svcs. S  Payne, MA, Occupational Lead Poisoning Prevention Program, California Dept 
o f Health Svcs. BC Jung , MPH, Connecticut Dept o f Public Health and Addiction Svcs . 
M Lehnherr, Occupational Disease Registry, Div o f Epidemiologic Studies, Illinois Dept o f  Public 
Health. R Gergely, Iowa Dept o f  Public Health. B Carvette, MPH, Occupational Health Program, 
Bur o f  Health, Maine Dept o f  Human Svcs. E Keyvan-Larijani, MD, Lead Poisoning Prevention 
Program, Maryland Dept o f  the Environment R Rabin, MSPH, Div o f Occupational Hygiene, 
M assachusetts Dept o f  Labor and Industries. M Scoblic, MN, Michigan Dept o f Public Health. L
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TABLE 1. Number of reports of elevated blood lead levels (BLLs) among adults, number 
of adults with elevated BLLs, and percentage change In number of reports — 
23 states,* first quarter, 1994-1995
Reported BLL 
(jig/dL)
First quarter, 1995
No. reports, 
first quarter, 
1994*
% Change 
first quarter, 
1994 to 1995No. reports No. persons5
25-39 4914 3635 4102 +20%
40-49 1197 878 1371 -13%
50-59 245 204 278 -12%
>60 82 58 117 -30%
Total 6438 4775 5868 +10%
* Alabama, Arizona, California, Connecticut, Illinois, Iowa, Maine, Maryland, Massachusetts, 
Michigan, New Hampshire, New Jersey, New York, North Carolina, Oklahoma, Oregon, Penn­
sylvania, South Carolina, Texas, Utah, Vermont, Washington, and Wisconsin.
"^Data for Maine are included. These data only recently became available for 1994 and were 
not included in previous reports.
individual reports for persons are categorized according to the highest reported BLL for the 
person during the given quarter. Pennsylvania provides the number of reports but not number 
of persons; the number of persons for Pennsylvania in this table are estimates based on the 
proportions from the other 22 states combined and the number of reports received from  
Pennsylvania. Data for South Carolina were missing; first quarter 1994 data were used as an 
estimate.
TABLE 2. Number of reports of elevated blood lead levels (BLLS) among adults, 
number of adults with elevated BLLS, and new cases of elevated BLLs— United States, 
1993 and 1994
Reported BLL 
(Hg/dL)
1994 (23 states)* 1993 (20 states)1'
No.
reports
No.
persons*
New cases^ No.
reports
No.
persons
New cases**
No. (%) No. (%)
25-39 19,420 8,651 4,254 (49) 18,529 8,041 4,693 (58)
40-49 5,821 2,562 887 (35) 5,398 2,293 1,288 (56)
50-59 1,132 644 269 (42) 1,311 627 419 (67)
>60§ 459 280 209 (75) 633 279 184 (66)
Total 26,832 12,137 5,619 (46) 25,871 11,240 6,584 (59)
^Alabama, Arizona, California, Connecticut, Illinois, Iowa, Maine, Maryland, Massachusetts, 
Michigan, New Hampshire, New Jersey, New York, North Carolina, Oklahoma, Oregon, 
Pennsylvania, South Carolina, Texas, Utah, Vermont, Washington, and Wisconsin. Data for 
Maine were not included in previous reports. Data for South Carolina were missing for 
fourth quarter 1994; fourth quarter 1993 data were used as an estimate.
+Same states as 1994 except Maine, North Carolina, and Oklahoma.
individual reports are categorized according to the highest reported BLL for the person 
during the given year. Pennsylvania provides the number of reports but not number of 
persons; the number of persons for Pennsylvania in this table are estimates based on the 
proportions from the other 22 states combined and the number of reports received from  
Pennsylvania. Data for South Carolina were missing for the fourth quarter 1994; fourth 
quarter 1993 data were used as an estimate.
^Illinois, Michigan, Pennsylvania and South Carolina did not report new cases for 1994. New  
cases for those four states are estimates based on the proportions from the other 19 states 
combined and the number of reports, persons, or unassigned new cases reported from  
these four states.
**N e w  cases for 1993 were not reported from Michigan, New Hampshire, and Pennsylvania. 
No estimates are included in the 1993 data.
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Thistie-Eliiott, MEd, Div o f  Public Health Svcs, N ew  Hampshire State Dept o f  Health and Human 
Svcs. B Gerwel, MD, Occupational Disease Prevention Project N ew  Jersey State Dept o f  Health. 
R Stone, PhDt N ew  York State Dept o f Health. S  Randolph, MSN, North Carolina Dept o f 
Environm ent Health, and Natural Resources. E Rhoades, MD, Oklahoma State Dept Health. 
A Sandoval, MS, State Health Div, Oregon Dept o f  Human Resources. J  Gostin, MS, Occupa­
tional Health Program, Div o f Environmental Health, Pennsylvania Dept o f  Health. R Marino, 
MD, Div o f Health Hazard Evaluations, South Carolina Dept o f Health and Environmental Con- 
trol. D Perrotta, PhD, Bur o f Epidemiology, Texas Dept o f Health. D Beaudoin, MD, Bur of 
Epidemiology, Utah Dept o f  Health. L Toof, Div o f Epidemiology and Health Promotion, Vermont 
Dept o f  Health. J  Kaufman, MDr Washington State Dept o f Labor and Industries. V Ingram-Ste- 
wart, MPH, Wisconsin Dept o f  Health and Social Svcs . Div o f Surveillance, Hazard Evaluations, 
and Field Studies, National Institute for Occupational Safety and Health, CDC.
Editorial Note: Approximately 54% of the persons reported to ABLES in 1993 were 
reported again to the system in 1994. Reasons for these repeat reports include 1) re­
curring exposure resulting from inadequate control measures and worker-protection 
practices; 2) routine tracking of elevated employee BLLs that remain below levels re­
quiring medical removal; and 3) increased employer monitoring during medical 
removal. Increased testing of workers in construction trades—as new workplace 
medical monitoring programs are established to comply with new OSHA regulations
( 3 )— also has contributed to the increases.
Reporting of adults with elevated BLLs reflects monitoring practices by employers. 
Variation in national quarterly reporting totals, especially first quarter totals, may re­
sult from 1) changes in the number of participating states, 2) timing of receipt of 
laboratory BLL reports by state-based surveillance programs, and 3) interstate differ­
ences in worker BLL testing by lead-using industries.
The data in this report underscore that work-related lead exposures are an ongoing 
occupational health problem in the United States. ABLES can further enhance surveil­
lance for this preventable condition by expanding the number of participating states, 
reducing variability in reporting, and distinguishing between new and recurring ele­
vated BLLs in adults. The Council of State and Territorial Epidemiologists, at its annual 
meeting in May 1995, designated elevated BLLs among adults as a condition report- 
able to the National Public Health Surveillance System (formerly the National 
Notifiable Diseases Surveillance System) (4).
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Erratum: Vol. 44, No. 17
In the article, "Prevalence and Impact of Arthritis Among Women— United States, 
1989-1991," a programming error led to incorrect estimates for nonarthritis condi­
tions listed in Table 2. The corrected table follows.
The error does not change statements in the text on the relative ranking of arthritis 
compared with other chronic conditions but does change the following: 1) under the
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